Heather Whaley, MD
Pain Medicine · Little Rock, ARNPI 1487098190
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 17 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 7 manufacturers reported payments, led by AbbVie at 30.6% of the total. Reporting peaked in 2019 at $202 and has fallen 91.4% since, to $17 in 2025. That places this record below the midpoint for pain medicine clinicians in AR, where the typical reported total is $3,271.
Across 17 payments — averaging $24.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$127
- Vertiflex, Inc.$122
- Medtronic$68
- Boston Scientific$43
- Pfizer$26
- Sun Pharmaceutical Industries Inc.$17
- plus $14 from 1 others
What the payments were for
- Food & beverage$416100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 8 | $127 |
| Vertiflex, Inc. | 1 | $122 |
| Medtronic(2 entities) | 2 | $68 |
| Boston Scientific | 2 | $43 |
| Pfizer | 2 | $26 |
| Sun Pharmaceutical Industries Inc. | 1 | $17 |
| Amgen | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Superion ISS$122
How this compares
$416 in reported general payments places this provider in the 20th percentile of 53 pain medicine providers in Arkansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 659 | $20,747 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 209 | $7,903 |
| Gabapentin | 394 | $6,174 |
| Pregabalin | 156 | $3,507 |
| Tizanidine Hcl | 277 | $3,497 |
| Butorphanol Tartrate | 28 | $3,019 |
| Buprenorphine | 15 | $2,888 |
| Cyclobenzaprine Hcl | 220 | $2,818 |
| Morphine Sulfate ErMorphine Sulfate | 23 | $1,627 |
| Buprenorphine Hcl | 31 | $1,388 |
| Tramadol Hcl | 119 | $1,343 |
| Oxycodone Hcl | 79 | $1,166 |
| Methocarbamol | 48 | $1,052 |
| Morphine Sulfate | 27 | $908 |
| Baclofen | 52 | $803 |
Paid to pharmacies, not to this prescriber.
Other pain medicine in Little Rock
- Stephen PaulusLittle Rock$75K
- Julio OlayaLittle Rock$22K
- Christopher MocekLittle Rock$10K
- Ann IkonneLittle Rock$8K
- Saint AdeogbaLittle Rock$6K
- Andrew CainLittle Rock$5K
- Krishnappa PrasadLittle Rock$5K
- Thomas HartLittle Rock$4K
- James CaldwellLittle Rock$4K
- Terry FletcherLittle Rock$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.